Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

35.75p
   
  • Change Today:
    -0.75p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 747,757
  • Market Cap: £129.23m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart (22-05-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -80.5% -7.1%
ROCE n/a  
Latest F'cast
P/E n/a 133.2
PEG n/a n/a
Pr/Revenue 4.2 2.3
Pr/Book 2.2  
Latest F'cast
Revenue 13.2% 83.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.17 (30.98) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 27.20 (30.90) (0.15)p n/a n/a n/a n/a 0.0%
31-Dec-24 30.80 (24.50) (0.07)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 56.35 (4.00) (0.29)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Final Results 15-May-2024 07:00 RNS
Directorate Changes 13-May-2024 07:00 RNS
Notice of Results 25-Apr-2024 07:00 RNS

CREO ShareCast News

Creo device used in 'groundbreaking' lung cancer... 01-Mar-2024 ShareCast
Creo Medical FY revenues up double digits 07-Feb-2024 ShareCast
Creo launches 'Speedboat Ultraslim' with first U... 13-Dec-2023 ShareCast

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 35.75p
Change Today -0.75p
% Change -2.05 %
52 Week High 48.10
52 Week Low 23.25
Volume 747,757
Shares Issued 361.48m
Market Cap £129.23m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.85% below the market average65.85% below the market average65.85% below the market average65.85% below the market average65.85% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Price Trend
19.51% above the market average19.51% above the market average19.51% above the market average19.51% above the market average19.51% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth
16.08% below the market average16.08% below the market average16.08% below the market average16.08% below the market average16.08% below the market average
27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 22-May-2024

Time Volume / Share Price
16:39 75,000 @ 35.68p
16:21 647 @ 35.65p
16:18 2,086 @ 35.65p
16:11 50,000 @ 35.75p
16:11 50,000 @ 35.75p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page